171 related articles for article (PubMed ID: 22415807)
1. Functional polymorphisms in the insulin-like binding protein-3 gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans.
Xu L; Mugartegui L; Li G; Sarlis NJ; Wei Q; Zafereo ME; Sturgis EM
Mol Carcinog; 2012 Oct; 51 Suppl 1(Suppl 1):E158-67. PubMed ID: 22415807
[TBL] [Abstract][Full Text] [Related]
2. Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma.
Xu L; Doan PC; Wei Q; Liu Y; Li G; Sturgis EM
Thyroid; 2012 Jan; 22(1):35-43. PubMed ID: 22136207
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.
Keku TO; Vidal A; Oliver S; Hoyo C; Hall IJ; Omofoye O; McDoom M; Worley K; Galanko J; Sandler RS; Millikan R
Cancer Causes Control; 2012 Jul; 23(7):1127-38. PubMed ID: 22565227
[TBL] [Abstract][Full Text] [Related]
4. Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma.
Xu L; Morari EC; Wei Q; Sturgis EM; Ward LS
J Clin Endocrinol Metab; 2012 Jun; 97(6):1913-21. PubMed ID: 22438227
[TBL] [Abstract][Full Text] [Related]
5. Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
Pellé L; Cipollini M; Tremmel R; Romei C; Figlioli G; Gemignani F; Melaiu O; De Santi C; Barone E; Elisei R; Seiser E; Innocenti F; Zanger UM; Landi S
Arch Toxicol; 2016 Dec; 90(12):3099-3109. PubMed ID: 26783003
[TBL] [Abstract][Full Text] [Related]
6. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
[TBL] [Abstract][Full Text] [Related]
7. IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans.
Hernandez W; Grenade C; Santos ER; Bonilla C; Ahaghotu C; Kittles RA
Carcinogenesis; 2007 Oct; 28(10):2154-9. PubMed ID: 17724372
[TBL] [Abstract][Full Text] [Related]
8. IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.
D'Aloisio AA; Schroeder JC; North KE; Poole C; West SL; Travlos GS; Baird DD
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):954-66. PubMed ID: 19240240
[TBL] [Abstract][Full Text] [Related]
9. Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer.
Akker M; Güldiken S; Sipahi T; Palabıyık O; Tosunoğlu A; Çelik Ö; Tunçbilek N; Sezer A; Süt N
Mol Biol Rep; 2014 May; 41(5):3541-7. PubMed ID: 24504452
[TBL] [Abstract][Full Text] [Related]
10. Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.
McGrath M; Lee IM; Buring J; De Vivo I
Gynecol Oncol; 2011 Feb; 120(2):174-8. PubMed ID: 21078522
[TBL] [Abstract][Full Text] [Related]
11. Family history of cancer and risk of sporadic differentiated thyroid carcinoma.
Xu L; Li G; Wei Q; El-Naggar AK; Sturgis EM
Cancer; 2012 Mar; 118(5):1228-35. PubMed ID: 21800288
[TBL] [Abstract][Full Text] [Related]
12. Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.
Zhang F; Xu L; Wei Q; Song X; Sturgis EM; Li G
Surgery; 2013 May; 153(5):711-7. PubMed ID: 23218882
[TBL] [Abstract][Full Text] [Related]
13. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
Safarinejad MR; Shafiei N; Safarinejad SH
Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
[TBL] [Abstract][Full Text] [Related]
14. RET polymorphisms and haplotypes and risk of differentiated thyroid cancer.
Ho T; Li G; Zhao C; Wei Q; Sturgis EM
Laryngoscope; 2005 Jun; 115(6):1035-41. PubMed ID: 15933516
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
[TBL] [Abstract][Full Text] [Related]
17. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population.
Han SG; Park KH; Sung JS; Whang YM; Kim YJ; Shin ES; Lee JW; Lee HJ; Ryu JS; Choi IK; Seo JH; Kim YH
Lung Cancer; 2008 Nov; 62(2):152-61. PubMed ID: 18450319
[TBL] [Abstract][Full Text] [Related]
19. IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly.
Akin F; Turgut S; Cirak B; Kursunluoglu R
Growth Horm IGF Res; 2010 Dec; 20(6):399-403. PubMed ID: 20920870
[TBL] [Abstract][Full Text] [Related]
20. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis.
Ho T; Li G; Lu J; Zhao C; Wei Q; Sturgis EM
Thyroid; 2009 Feb; 19(2):129-35. PubMed ID: 19191745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
